Internal Medicine, Rheumatology · Boston, MA
NPI
1053393074
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
55 Fruit St, Bul 165
Boston, MA, 02114
Phone (617) 726-2870
Groups this clinician bills Medicare through
Medicare paid, 2024
$111K
7,287 services
Medicare patients, 2024
559
Average age 74
Drug cost, 2024
$5.8M
5,062 prescriptions
Company payments, 2025
$43.25
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert P Friday was code J1010 (injection, methylprednisolone acetate, 1 mg), 5,860 times for 47 patients. In total Robert P Friday billed 7,287 services in 23 codes, and Medicare paid $111K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 5,860 | 47 | $0.10 | $595 |
| 99214 Office E&M - Established | Office | 495 | 302 | $103.26 | $51K |
| 99213 Office E&M - Established | Office | 165 | 127 | $71.69 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 165 | 140 | $13.82 | $2,280 |
| 99214 Office E&M - Established | Facility | 122 | 65 | $75.65 | $9,230 |
| 20610 Joint Injection | Office | 77 | 47 | $66.45 | $5,117 |
| 99204 Office E&M - New | Office | 61 | 61 | $134.62 | $8,212 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 57 | 29 | $4.77 | $272 |
| 99215 Office E&M - Established | Office | 54 | 40 | $144.43 | $7,799 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 43 | 36 | $13.82 | $594 |
| 20610 Joint Injection | Facility | 23 | 17 | $39.84 | $916 |
| 99213 Office E&M - Established | Facility | 22 | 17 | $52.50 | $1,155 |
| 99205 Office E&M - New | Office | 20 | 20 | $185.50 | $3,710 |
| 20600 Joint Injection | Office | 16 | 11 | $48.54 | $777 |
By year: 2022 $105K for 1,427 services; 2023 $114K for 1,491 services; 2024 $111K for 7,287 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert P Friday prescribed most often to Medicare patients was Prednisone, with 563 prescriptions and refills. In total Robert P Friday wrote 5,062 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 563 | 958 | 194 | $5,160 |
| Hydroxychloroquine Sulfate Generic | 432 | 1,011 | 124 | $16K |
| Methotrexate Methotrexate Sodium | 410 | 1,002 | 125 | $14K |
| Celecoxib Generic | 397 | 594 | 105 | $8,178 |
| Tramadol Hcl Generic | 135 | 155 | 32 | $699 |
| Duloxetine Hcl Generic | 132 | 256 | 32 | $6,080 |
| Leucovorin Calcium Generic | 131 | 321 | 40 | $4,575 |
| Gabapentin Generic | 123 | 253 | 38 | $2,570 |
| Pregabalin Generic | 120 | 152 | 25 | $2,261 |
| Meloxicam Generic | 119 | 231 | 39 | $470 |
| Allopurinol Generic | 111 | 294 | 31 | $1,444 |
| Leflunomide Generic | 108 | 266 | 34 | $9,531 |
| Colchicine Generic | 107 | 251 | 41 | $9,316 |
| Methylprednisolone Generic | 107 | 150 | 46 | $2,735 |
| Humira(Cf) Pen Adalimumab | 103 | 109 | 15 | $837K |
Brand drugs: - claims; generic drugs: 4,155 claims; opioid claims: 296.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert P Friday $43.25 ($43.25 in general payments such as food, travel and fees) from 1 company. The largest payer was AstraZeneca Pharmaceuticals LP with $43.25.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $43.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.